Recurrent TNC::PDGFD Fusions in Ossifying Plexiform Tumors of the Skin
Modern Pathology · 2026
DOI: 10.1016/j.modpat.2026.101042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Shira Ronen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio. Hauptthemen laut MEDLINE: Skin Neoplasms, Lymphokines, Platelet-Derived Growth Factor, Biomarkers, Tumor. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PDGFB or, more rarely, PDGFD rearrangements are well-established oncogenic drivers of dermatofibrosarcoma protuberans (DFSP). Recently, a TNC::PDGFD fusion has been identified in a superficial spindle cell tumor distinct from DFSP but similar to the tumor entity described as ossifying plexiform tumors of the skin. Herein, we report 7 additional cases of cutaneous ossifying plexiform tumors harboring a TNC::PDGFD fusion transcript. Four patients were female. Tumors were located on the nose (n = 2), hand (n = 2), forearm (n = 1), flank (n = 1), and foot (n = 1), with a median size of 6 (range, 4-9) mm. Microscopically, these neoplasms were located in the dermis (n = 6) and subcutaneous tissues (n = 1). All specimens exhibited a lobulated architecture and a biphasic appearance characterized by the association of cellular areas composed of bland spindle cells with central regions of bone formation. Immunohistochemistry showed SATB2 positivity in all tested tumors (n = 4). RNA-sequencing analysis confirmed the presence of the TNC::PDGFD fusion transcript in all cases and revealed a transcriptomic profile that was distinct from other soft tissue tumors, including DFSP. Our findings support that TNC::PDGFD is the oncogenic driver of ossifying plexiform tumor of the skin, a rare tumor distinct from DFSP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio.
- Department of Biopathology, Center Léon Bérard, Lyon, France.
- Bioptická Laboratoř, Pilsen, Czech Republic; Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic.
- Department of Dermatology and Pathology, West Virginia University, Morgantown, West Virginia.
- Department of Pathology, Aix Marseille University, INSERM, APHM MMG, UMR1251, La Timone Hospital, Marseille, France.
- Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
Zitieren
APA
Ronen, S., Meurgey, A., Michal, M., Pissaloux, D., Tirode, F., Beatty, C. J., Macagno, N., de Pinieux, G., Cassarino, D. S., Ortonne, N., Lamant, L., Calonje, E., Tetzlaff, M., LeBoit, P. E., Billings, S. D., & Kervarrec, T. (2026). Recurrent TNC::PDGFD Fusions in Ossifying Plexiform Tumors of the Skin. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.101042
Vancouver
Ronen S, Meurgey A, Michal M, Pissaloux D, Tirode F, Beatty CJ, et al. Recurrent TNC::PDGFD Fusions in Ossifying Plexiform Tumors of the Skin. Modern Pathology. 2026. doi:10.1016/j.modpat.2026.101042
BibTeX
@article{Ronen2026,
author = {Ronen, Shira and Meurgey, Alexandra and Michal, Michael and Pissaloux, Daniel and Tirode, Franck and Beatty, Colleen J and Macagno, Nicolas and de Pinieux, Gonzague and Cassarino, David S and Ortonne, Nicolas and Lamant, Laurence and Calonje, Eduardo and Tetzlaff, Michael and LeBoit, Philip E and Billings, Steven D and Kervarrec, Thibault},
title = {Recurrent TNC::PDGFD Fusions in Ossifying Plexiform Tumors of the Skin},
journal = {Modern Pathology},
year = {2026},
doi = {10.1016/j.modpat.2026.101042}
}
EUVIMED